Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985–2012: a population-based study

Clinical and Translational Oncology

Volumn 18, Issue 5, 2016, Pages 489-496

  Linares, I ^a   Molina Portillo, E ^a,b,c,d   Exposito J ^a   Baeyens, J A ^d,e   Suarez C ^f   Sanchez M J ^a,b,c,d  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d Public Health and Epidemiology CIBER ^*  (Spain)

^e University Health Centre of La Chana   (Spain)

^f UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Histologic types; Incidence; Lung cancer; Population based study; Sex differences; Trends

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER REGISTRY; CHILD; FEMALE; GENDER; HISTOLOGY; HUMAN; ICD-O-2; ICD-O-3; INCIDENCE; INFANT; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEWBORN; SMALL CELL LUNG CANCER; SPAIN; SQUAMOUS CELL LUNG CARCINOMA; ADENOCARCINOMA; CANCER STAGING; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FOLLOW UP; LUNG NEOPLASMS; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; REGISTER; SMALL CELL LUNG CARCINOMA; TIME FACTOR; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; SMALL CELL LUNG CARCINOMA; SPAIN; TIME FACTORS; YOUNG ADULT;

EID: 84940501368     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-015-1392-x     Document Type: Article

References (30)

1. Brambilla E, Travis WD. Lung cancer. In: Stewart BW, Wild CP, editors. World cancer report. Lyon: World Health Organization; 2014.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.
3. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.
4. Steliarova-Foucher E, O’callaghan M, Ferlay J, Masuyer E, Forman D, Comber H, et al. European cancer Observatory: cancer incidence, mortality, prevalence and survival in Europe. Version 1.0 (September 2012). European Network of Cancer Registries. International Agency for Research on Cancer; 2012. http://cco.iarc.fr.
5. Sánchez MJ, Payer T, De Angelis R, Larrañaga N, Capocaccia R, Martinez C. Cancer incidence and mortality in Spain: estimates and projections for the period 1981–2012. Ann Oncol: ESMO. 2010;21 Suppl 3(Supplement 3):iii30–6.
6. Pesch B, Kendzia B, Gustavsson P, Jöckel KH, Johnen G, Pohlabeln H, et al. Cigarette smoking and lung cancer–relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer. 2012;131(5):1210–9.
7. Ridge CA, McErlean AM, Ginsberg MS. Epidemiology of lung cancer. Semin Intervent Radiol. 2013;30(2):93–8.
8. Remon J, Molina-Montes E, Majem M, Lianes P, Isla D, Garrido P, et al. Lung cancer in women: an overview with special focus on Spanish women. Clin Transl Oncol. 2014;16:517–28.
9. Fernandez E, Schiaffino A, Borràs JM, Shafey O, Villalbí JR, La Vecchia C. Prevalence of cigarette smoking by birth cohort among males and females in Spain 1010–1990. Eur J Cancer Prev. 2003;12:57–62.
10. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population based study of 20561 cases. Ann Oncol. 2002;13(13):1087–93.
11. Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CW Jr. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst. 1997;89:1580–6.
12. Salmerón D, Chirlaque MD, Izarzugaza MI, Sánchez MJ, Marcos-Gragera R, Ardanaz E, et al. Lung cancer prognosis in Spain: the role of histology, age and sex. Respir Med. 2012;106:1301–8.
13. Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male: female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 2005;117(2):294–9.
14. Toyoda Y, Nakayama T, Ioka A, Tsukuma H. Trends in lung cancer incidence by histological type in Osaka, Japan. Jpn J Clin Oncol. 2008;38:534–9.
15. Keohavong P, De Michele MA, Melacrinos AC, Landreneau RJ, Weyant RJ, Siegfried JM. Detection of K-ras mutations in lung carcinomas: relationship to prognosis. Clin Cancer Res. 1996;2:411–8.
16. World Health Organization (WHO). International statistical classification of diseases and related health problems, 10th Revision. ICD-10 WHO; version 2015. http://apps.who.int/classifications/icd10/browse/2015/en#/C30-C39.
17. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al., editors. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
18. Percy C, Van Holten V, Muir C, editors. International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization; 1990.
19. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, editors. World Health Organization classification of tumours. pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004.
20. Bray FI, Weiderpass E. Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970–2007. Int J Cancer. 2010;126:1454–66.
21. De la Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011;32(4):605–44. doi:10.1016/j.ccm.2011.09.001.
22. Bosetti C, Malvezzi M, Rosso T, Bertuccio P, Gallus S, Chatenoud L, et al. Lung cancer mortality in European women: trends and predictions. Lung Cancer. 2012;78:171–8.
23. Levi F, Bosetti C, Fernandez E, Hill C, Lucchini F, Negri E, et al. Trends in lung cancer among young European women: the rising epidemic in France and Spain. Int J Cancer. 2007;121:462–5.
24. La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, et al. Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol. 2010;21:1323–60.
25. Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Weiderpass E, Bray F. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer. 2014;84(1):13–22. doi:10.1016/j.lungcan.2014.01.009.
26. Jemal A, Travis WD, Tarone RE, Travis L, Devesa SS. Lung cancer rates convergence in young men and women in the United States: analysis by birth cohortand histologic type. Int J Cancer. 2003;105:101–7.
27. Everatt R, Kuzmickiene I, Senulis A. Cigarette smoking and trends in lung cancer incidence in Lithuania: an analysis by histological type. Medicina (Kaunas). 2011;47:222–9.
28. Patel JD, Bach PB, Kris MG. Lung cancer in US women: a contemporary epidemic. JAMA. 2004;291(14):1763–8.
29. Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rate in lifelong nonsmokers. J Natl Cancer Inst. 2006;98:691–9.
30. Patel JD. Lung cancer in women. J Clin Oncol. 2005;23:3212–8.